FYERS
Home
/
Stocks
/
Results
/
Bliss GVS Pharma Results

Bliss GVS Pharma Results

Financial overview

CAGR%
Sales
Profits
Returns
ROE
10Y5Y3YTTM
5%10%7%14%
5%14%22%49%
17%44%96%353%
13%8%10%12%

Peer Comparison

Symbol
SUNPHARMA
DIVISLAB
TORNTPHARM
ZYDUSLIFE
CIPLA
LAURUSLABS
MANKIND
DRREDDY
AUROPHARMA
LUPIN
BLISSGVS-BE
PriceM.Cap (₹)PE RatioEPS (₹)EV/EBITDAAnnual PAT
1,849.9₹447476 Cr3712.0762.82₹11479 Cr
9,602₹254764 Cr87.134.04128.41₹2568 Cr
4,928.5₹189423 Cr86.8516.7297.06₹2163 Cr
1,180.3₹116658 Cr25.859.4262.53₹5040 Cr
1,399₹111484 Cr33.089.7757.87₹3879 Cr
2,026.2₹109943 Cr100.556.829.25₹889 Cr
2,500₹101712 Cr49.7913.7571.08₹1913 Cr
1,200.4₹101005 Cr31.355.3263.99₹4196 Cr
1,716₹99253 Cr26.7317.9596.84₹3505 Cr
2,100.7₹96031 Cr17.3730.95154.35₹5333 Cr
685.1₹7411 Cr54.424.7216.12₹129 Cr

Profit & Loss

Consolidated
Standalone
Quarterly
Yearly
₹
%

Balance Sheet

Consolidated
Standalone
₹
%
Name
Equity And Liabilities
Share Capital
Share Warrants & Outstandings
Total Reserves
Reserve excluding Revaluation Reserve
Shareholder's Funds
Minority Interest
Secured Loans
Unsecured Loans
Deferred Tax Assets / Liabilities
Other Long Term Liabilities
Long Term Provisions
Total Non-Current Liabilities
Current Liabilities
Trade Payables
Other Current Liabilities
Short Term Borrowings
Short Term Provisions
Total Current Liabilities
Total Liabilities
Contingent Liabilities
Total Debt
Assets
Gross Block
Less Accumulated Depreciation
Net Block
Capital Work in Progress
Non Current Investments
Long Term Investment
Long Term Loans & Advances
Other Non Current Assets
Total Non-Current Assets
Current Assets Loans & Advances
Currents Investments
Inventories
Sundry Debtors
Cash and Bank
Other Current Assets
Short Term Loans and Advances
Total Current Assets
Net Current Assets (Including Current Investments)
Miscellaneous Expenses not written off
Total Assets
Book Value
Adjusted Book Value
Mar 2026Mar 2025Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020Mar 2019Mar 2018Mar 2017Mar 2016Mar 2015Mar 2014Mar 2013Mar 2012Mar 2011
————————————————
₹11 Cr₹11 Cr₹10 Cr₹10 Cr₹10 Cr₹10 Cr₹10 Cr₹10 Cr₹10 Cr₹10 Cr₹10 Cr₹10 Cr₹10 Cr₹10 Cr₹10 Cr₹10 Cr
₹12 Cr₹6 Cr₹8 Cr₹9 Cr₹10 Cr₹10 Cr₹0₹0₹0₹0₹0₹0₹0₹0₹0₹0
₹1171 Cr₹1034 Cr₹949 Cr₹865 Cr₹798 Cr₹788 Cr₹725 Cr₹636 Cr₹526 Cr₹476 Cr₹402 Cr₹327 Cr₹277 Cr₹248 Cr₹200 Cr₹156 Cr
₹1171 Cr₹1034 Cr₹949 Cr₹865 Cr₹798 Cr₹788 Cr₹725 Cr₹636 Cr₹526 Cr₹476 Cr₹402 Cr₹327 Cr₹277 Cr₹248 Cr₹200 Cr₹156 Cr
₹1193 Cr₹1050 Cr₹967 Cr₹884 Cr₹819 Cr₹808 Cr₹736 Cr₹646 Cr₹536 Cr₹487 Cr₹413 Cr₹337 Cr₹287 Cr₹258 Cr₹211 Cr₹167 Cr
₹39 Cr₹41 Cr₹36 Cr₹34 Cr₹28 Cr₹20 Cr₹15 Cr₹14 Cr₹11 Cr₹66 Cr₹33 Cr₹15 Cr₹10 Cr₹14 Cr₹49,000₹0
₹0₹20 Cr₹36 Cr₹41 Cr₹23 Cr₹33 Cr₹37 Cr₹33 Cr₹6 Cr₹26 Cr₹30 Cr₹55 Cr₹79 Cr₹90 Cr₹38 Cr₹4 Cr
₹0₹0₹0₹0₹0₹0₹0₹0₹0₹0₹9 Cr₹2 Cr₹9 Cr₹1 Cr₹0₹0
-₹16 Cr₹30 L₹4 Cr-₹3 Cr₹1 Cr₹8 Cr₹4 Cr₹4 Cr₹5 Cr₹5 Cr₹9 Cr₹9 Cr₹7 Cr₹5 Cr₹1 Cr-₹37 L
₹22 Cr₹13 Cr₹9 Cr₹3 Cr₹4 Cr₹2 Cr₹3 Cr₹13 L₹0₹40,000₹0₹0₹0₹0₹0₹0
₹3 Cr₹4 Cr₹3 Cr₹3 Cr₹1 Cr₹2 Cr₹2 Cr₹2 Cr₹2 Cr₹2 Cr₹2 Cr₹1 Cr₹1 Cr₹74 L₹51 L₹58 L
₹9 Cr₹37 Cr₹51 Cr₹43 Cr₹29 Cr₹45 Cr₹46 Cr₹38 Cr₹13 Cr₹33 Cr₹50 Cr₹68 Cr₹96 Cr₹97 Cr₹39 Cr₹4 Cr
————————————————
₹104 Cr₹71 Cr₹61 Cr₹86 Cr₹93 Cr₹74 Cr₹90 Cr₹79 Cr₹58 Cr₹98 Cr₹108 Cr₹80 Cr₹82 Cr₹118 Cr₹40 Cr₹31 Cr
₹94 Cr₹73 Cr₹62 Cr₹58 Cr₹68 Cr₹54 Cr₹57 Cr₹50 Cr₹124 Cr₹100 Cr₹53 Cr₹70 Cr₹42 Cr₹24 Cr₹6 Cr₹4 Cr
₹3 Cr₹23 Cr₹32 Cr₹46 Cr₹61 Cr₹65 Cr₹66 Cr₹64 Cr₹106 Cr₹187 Cr₹62 Cr₹61 Cr₹57 Cr₹45 Cr₹6 Cr₹3 Cr
₹35 Cr₹4 Cr₹2 Cr₹3 Cr₹12 Cr₹11 Cr₹17 Cr₹14 Cr₹11 Cr₹51 Cr₹156 Cr₹31 Cr₹126 Cr₹14 Cr₹8 Cr₹4 Cr
₹236 Cr₹172 Cr₹157 Cr₹193 Cr₹233 Cr₹204 Cr₹231 Cr₹207 Cr₹299 Cr₹437 Cr₹379 Cr₹243 Cr₹308 Cr₹202 Cr₹60 Cr₹43 Cr
₹1476 Cr₹1301 Cr₹1212 Cr₹1154 Cr₹1109 Cr₹1077 Cr₹1027 Cr₹905 Cr₹860 Cr₹1023 Cr₹874 Cr₹662 Cr₹700 Cr₹571 Cr₹310 Cr₹213 Cr
₹11 Cr₹5 Cr₹57 Cr₹12 Cr₹23 Cr₹30 Cr₹14 Cr₹2 Cr₹4 Cr₹44 Cr₹30 Cr₹40 Cr₹48 Cr₹44 Cr₹51 Cr₹12 Cr
₹3 Cr₹71 Cr₹88 Cr₹98 Cr₹105 Cr₹119 Cr₹121 Cr₹102 Cr₹118 Cr₹225 Cr₹132 Cr₹160 Cr₹173 Cr₹147 Cr₹45 Cr₹8 Cr
————————————————
₹607 Cr₹531 Cr₹468 Cr₹459 Cr₹343 Cr₹285 Cr₹276 Cr₹170 Cr₹157 Cr₹327 Cr₹301 Cr₹294 Cr₹262 Cr₹206 Cr₹64 Cr₹41 Cr
₹149 Cr₹126 Cr₹98 Cr₹81 Cr₹63 Cr₹51 Cr₹35 Cr₹25 Cr₹21 Cr₹23 Cr₹75 Cr₹59 Cr₹49 Cr₹38 Cr₹24 Cr₹21 Cr
₹459 Cr₹405 Cr₹369 Cr₹378 Cr₹281 Cr₹234 Cr₹241 Cr₹145 Cr₹136 Cr₹304 Cr₹225 Cr₹234 Cr₹213 Cr₹168 Cr₹40 Cr₹20 Cr
₹6 Cr₹21 Cr₹8 Cr₹3 Cr₹22 Cr₹2 Cr₹0₹47 Cr₹47 L₹4 Cr₹9 Cr₹0₹4 Cr₹65 L₹6 Cr₹8 Cr
₹4 Cr₹4 Cr₹4 Cr₹3 Cr₹2 Cr₹1 L₹72 L₹72 L₹6 Cr₹1 Cr₹11 L₹1 L₹1 L₹1 L₹1,000₹1,000
₹4 Cr₹4 Cr₹4 Cr₹3 Cr₹2 Cr₹1 L₹72 L₹72 L₹6 Cr₹1 Cr₹11 L₹1 L₹1 L₹1 L₹1,000₹1,000
₹30 Cr₹20 Cr₹15 Cr₹18 Cr₹24 Cr₹13 Cr₹15 Cr₹19 Cr₹27 Cr₹11 Cr₹57 Cr₹10 Cr₹12 Cr₹51 Cr₹53 Cr₹29 Cr
₹31 Cr₹27 Cr₹5 Cr₹54 Cr₹1 Cr₹62 Cr₹1 Cr₹33 L₹29 L₹137 Cr₹0₹0₹0₹0₹0₹0
₹530 Cr₹477 Cr₹401 Cr₹456 Cr₹332 Cr₹312 Cr₹257 Cr₹211 Cr₹170 Cr₹457 Cr₹291 Cr₹245 Cr₹230 Cr₹220 Cr₹100 Cr₹57 Cr
————————————————
₹1 Cr₹0₹56 L₹5 Cr₹0₹0₹0₹0₹0₹1,000₹0₹0₹0₹0₹80 L₹0
₹151 Cr₹126 Cr₹118 Cr₹103 Cr₹124 Cr₹99 Cr₹74 Cr₹77 Cr₹59 Cr₹49 Cr₹39 Cr₹34 Cr₹33 Cr₹33 Cr₹13 Cr₹12 Cr
₹517 Cr₹439 Cr₹404 Cr₹385 Cr₹393 Cr₹464 Cr₹548 Cr₹461 Cr₹298 Cr₹254 Cr₹301 Cr₹247 Cr₹215 Cr₹245 Cr₹129 Cr₹120 Cr
₹167 Cr₹213 Cr₹216 Cr₹103 Cr₹178 Cr₹145 Cr₹103 Cr₹107 Cr₹89 Cr₹151 Cr₹78 Cr₹57 Cr₹80 Cr₹50 Cr₹58 Cr₹18 Cr
₹14 Cr₹15 Cr₹17 Cr₹7 Cr₹14 Cr₹18 Cr₹16 Cr₹26 Cr₹97 Cr₹33 Cr₹15 Cr₹18 Cr₹11 Cr₹12 Cr₹4 Cr₹5 Cr
₹96 Cr₹24 Cr₹55 Cr₹95 Cr₹69 Cr₹40 Cr₹28 Cr₹23 Cr₹146 Cr₹78 Cr₹150 Cr₹61 Cr₹130 Cr₹9 Cr₹5 Cr₹3 Cr
₹946 Cr₹817 Cr₹811 Cr₹697 Cr₹777 Cr₹765 Cr₹770 Cr₹693 Cr₹690 Cr₹566 Cr₹583 Cr₹417 Cr₹469 Cr₹349 Cr₹210 Cr₹157 Cr
₹711 Cr₹644 Cr₹653 Cr₹504 Cr₹544 Cr₹562 Cr₹539 Cr₹486 Cr₹390 Cr₹129 Cr₹204 Cr₹174 Cr₹162 Cr₹147 Cr₹150 Cr₹114 Cr
₹0₹0₹0₹0₹0₹0₹0₹0₹0₹0₹0₹43 L₹1 Cr₹2 Cr₹0₹0
₹1476 Cr₹1301 Cr₹1212 Cr₹1154 Cr₹1109 Cr₹1077 Cr₹1027 Cr₹905 Cr₹860 Cr₹1023 Cr₹874 Cr₹662 Cr₹700 Cr₹571 Cr₹310 Cr₹213 Cr
₹112₹99₹92₹84₹78₹77₹71₹63₹52₹47₹40₹33₹28₹25₹20₹16
₹112₹99₹92₹84₹78₹77₹71₹63₹52₹47₹40₹33₹28₹25₹20₹16

Cash Flow

Consolidated
Standalone
₹
%
Name
Profit Before Tax
Adjustment
Changes In working Capital
Cash Flow after changes in Working Capital
Cash Flow from Operating Activities
Cash Flow from Investing Activities
Cash Flow from Financing Activitie
Net Cash Inflow / Outflow
Opening Cash & Cash Equivalents
Cash & Cash Equivalent on Amalgamation / Take over / Merger
Effect of Foreign Exchange Fluctuations
Closing Cash & Cash Equivalent
Mar 2026Mar 2025Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020Mar 2019Mar 2018Mar 2017Mar 2016Mar 2015Mar 2014Mar 2013Mar 2012Mar 2011
₹190 Cr₹126 Cr₹146 Cr₹106 Cr₹128 Cr₹104 Cr₹129 Cr₹182 Cr₹179 Cr₹175 Cr₹148 Cr₹96 Cr₹71 Cr₹109 Cr₹79 Cr₹0
₹96 Cr₹71 Cr₹38 Cr₹58 Cr-₹32 Cr₹46 Cr₹27 Cr-₹11 Cr₹18 Cr₹36 Cr₹18 Cr₹17 Cr₹24 Cr₹10 Cr₹5 Cr₹0
-₹104 Cr-₹51 Cr-₹47 Cr-₹85 Cr₹73 Cr-₹58 Cr-₹70 Cr-₹183 Cr-₹141 Cr₹113 Cr-₹8 Cr-₹67 Cr-₹19 Cr-₹74 Cr-₹38 Cr₹0
₹181 Cr₹145 Cr₹138 Cr₹79 Cr₹169 Cr₹93 Cr₹85 Cr-₹12 Cr₹56 Cr₹325 Cr₹158 Cr₹46 Cr₹75 Cr₹45 Cr₹46 Cr₹0
₹139 Cr₹106 Cr₹103 Cr₹34 Cr₹135 Cr₹64 Cr₹47 Cr₹40 Cr₹18 Cr₹289 Cr₹113 Cr₹38 Cr₹41 Cr₹7 Cr₹35 Cr₹0
-₹38 Cr-₹76 Cr-₹83 Cr-₹8 Cr-₹93 Cr-₹47 Cr-₹48 Cr-₹74 Cr₹50 Cr-₹231 Cr-₹50 Cr-₹29 Cr-₹11 Cr-₹124 Cr-₹22 Cr₹0
-₹89 Cr-₹30 Cr-₹21 Cr-₹25 Cr-₹24 Cr-₹21 Cr-₹6 Cr₹17 Cr-₹76 Cr-₹10 Cr-₹40 Cr-₹42 Cr-₹8 Cr₹110 Cr₹26 Cr₹0
₹11 Cr₹13 L-₹1 Cr₹2 Cr₹19 Cr-₹4 Cr-₹7 Cr-₹17 Cr-₹8 Cr₹48 Cr₹23 Cr-₹33 Cr₹22 Cr-₹8 Cr₹40 Cr₹0
₹24 Cr₹24 Cr₹25 Cr₹22 Cr₹13 Cr₹15 Cr₹15 Cr₹37 Cr₹47 Cr₹0₹5 Cr₹39 Cr₹28 Cr₹58 Cr₹18 Cr₹0
₹0₹0₹0₹0₹0₹0₹5 L₹0₹0₹17 Cr₹0₹0₹0₹0₹0₹0
₹10 L₹10 L-₹15 L₹1 Cr-₹10 Cr₹2 Cr₹8 Cr-₹5 Cr-₹2 Cr-₹18 Cr-₹34 L-₹53 L₹0₹0₹0₹0
₹35 Cr₹24 Cr₹24 Cr₹25 Cr₹22 Cr₹13 Cr₹15 Cr₹15 Cr₹37 Cr₹47 Cr₹28 Cr₹5 Cr₹50 Cr₹50 Cr₹58 Cr₹0

Fundamental Ratios

Consolidated
Standalone

Share Price Live Stats

Open (₹)707.75
Volume (₹)1.60 L
High (₹)707.75
Upper Circuit734.15
Low (₹)680.00
Lower Circuit664.25
Prev Close699.20
52W High (₹)728.00
Price685.10
52W Low (₹)118.00

Share Market Cap & Key Ratios Overview

M.Cap (₹)7410.70 Cr
Div. Yield (%)0.22
PE Ratio54.42
Debt to Equity0.00
Price to Book1.93
Book Value111.66
EPS (TTM)12.81
Face Value1.00
ROE (%)12.11

Stock Analysis (SWOT)

StrengthsWeaknessesOpportunitiesThreats
1. Premium insight available after login
2. Sign in to view full SWOT analysis
3. Unlock strengths, weaknesses, opportunities & threats
Sign in to view
Open a free Demat account in minutes to start investing and screening .
LoginSign Up

QVT

Quality
0/100-
Valuation
0/100-
Technical
0/100-
Sign in to view
Open a free Demat account in minutes to start investing and screening .
LoginSign Up

Peer Stocks

1 week
1 month
1 year
Name
SUNPHARMANSE
DIVISLABNSE
TORNTPHARMNSE
ZYDUSLIFENSE
CIPLANSE
LAURUSLABSNSE
MANKINDNSE
DRREDDYNSE
AUROPHARMANSE
LUPINNSE
BLISSGVS-BENSE
LTP
1W Low
1W High
Market cap (₹)
1849.9+12.6 (0.69%)
1832.20
1891.50
4,47,476Cr
9602+227 (2.42%)
9312.50
9740
2,54,764Cr
4928.5+88.5 (1.83%)
4848.50
5010
1,89,423Cr
1180.3+20.3 (1.75%)
1152.10
1190.60
1,16,658Cr
1399+4.5 (0.32%)
1364.50
1419
1,11,484Cr
2026.2+72.2 (3.69%)
1963.80
2055.30
1,09,943Cr
2500+199.3 (8.66%)
2303
2504.30
1,01,712Cr
1200.4+15.4 (1.30%)
1185
1222
1,01,005Cr
1716-18 (-1.04%)
1689.30
1740
99,253Cr
2100.7+17.7 (0.85%)
2080
2135
96,031Cr
685.1+3.25 (0.48%)
651.55
717
7,411Cr

Bliss GVS Pharma Ltd Annual Results Key Takeaways

Operating profit (before other income, interest and exceptional items) was ₹86Cr; with other income of ₹9.6Cr, profit before interest and tax came to ₹76.06Cr. Interest expense was ₹57.9Lakh; PBT before exceptional items stood at ₹75.48Cr. Cost mix (full year): raw materials ₹447.51Cr; employee cost ₹136.43Cr; depreciation ₹9.94Cr; other expenses ₹209.18Cr. Basis: consolidated annual results.

Bliss GVS Pharma Ltd Quaterly Results Key Takeaways

Bliss GVS Pharma Ltd reported ₹285.58Cr total income from operations in Jun 2026, softer than ₹256.99Cr in Mar 2026 but higher than ₹207.47Cr in Jun 2025. Operating profit (before other income, interest and exceptional items) was ₹86Cr; with other income of ₹9.6Cr, profit before interest and tax came to ₹76.06Cr. Interest expense was ₹57.9Lakh, taking profit before tax to ₹75.48Cr. After tax of ₹24.11Cr, profit after tax stood at ₹51.37Cr (vs ₹37Cr in Mar 2026 and ₹44.36Cr in Jun 2025).